{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:16:51Z","timestamp":1790299011674,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071509"],"award-info":[{"award-number":["82071509"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbih.2025.101015","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:19:21Z","timestamp":1747718361000},"page":"101015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The effect of dual inflammation on the acute phase clinical outcomes of schizophrenia patients with comorbid COVID-19"],"prefix":"10.1016","volume":"46","author":[{"given":"Jiahui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-1189","authenticated-orcid":false,"given":"Chuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2025.101015_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2025.03.008","article-title":"Toxoplasmosis infection and schizophrenia: elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia","volume":"278","author":"Alvim","year":"2025","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.bbih.2025.101015_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"Boldrini","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbih.2025.101015_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2020.05.005","article-title":"The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research","volume":"222","author":"Brown","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101015_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2025.101015_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.schres.2024.07.036","article-title":"Increased COVID-19 mortality in patients with schizophrenia: a retrospective study in Brazil","volume":"271","author":"Costa","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101015_bib6","doi-asserted-by":"crossref","unstructured":"Crunfli F, Carregari VC, Veras FP, et al. SARS-CoV-2 Infects Brain Astrocytes of COVID-19 Patients and Impairs Neuronal Viability. Published online July 7, 2021:2020.10.09.20207464. doi:10.1101\/2020.10.09.20207464.","DOI":"10.1101\/2020.10.09.20207464"},{"key":"10.1016\/j.bbih.2025.101015_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102188","article-title":"Neuropsychiatric aspects of COVID-19 pandemic: a selective review","volume":"53","author":"Dinakaran","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.bbih.2025.101015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","article-title":"Peripheral immune markers and antipsychotic non-response in psychosis","volume":"230","author":"Enache","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101015_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2021.12.022","article-title":"Impact of conspiracist ideation and psychotic-like experiences in patients with schizophrenia during the COVID-19 crisis","volume":"146","author":"Escol\u00e0-Gasc\u00f3n","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/brainsci11010058","article-title":"Neutrophil-to-Lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio in bipolar disorder","volume":"11","author":"Fusar-Poli","year":"2021","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-clinpsy-081122-013201","article-title":"Immune dysfunction in schizophrenia spectrum disorders","volume":"20","author":"Gangadin","year":"2024","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.bbih.2025.101015_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.psychres.2018.08.042","article-title":"Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia","volume":"269","author":"Gonzalez-Blanco","year":"2018","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.bbih.2025.101015_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib14","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12991-023-00435-4","article-title":"Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia","volume":"22","author":"Haddad","year":"2023","journal-title":"Ann. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12991-023-00435-4","article-title":"Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia","volume":"22","author":"Haddad","year":"2023","journal-title":"Ann. Gen. Psychiatr."},{"issue":"3","key":"10.1016\/j.bbih.2025.101015_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning. A modified scale","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.bbih.2025.101015_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"23","key":"10.1016\/j.bbih.2025.101015_bib19","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bbih.2025.101015_bib20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbih.2025.101015_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2023.03.016","article-title":"Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population","volume":"379","author":"Hua","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"10223","key":"10.1016\/j.bbih.2025.101015_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10323","key":"10.1016\/j.bbih.2025.101015_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.bbih.2025.101015_bib24","article-title":"The relationship between peripheral immune cell markers and cognitive functions in patients with schizophrenia","author":"Karahan","year":"2024","journal-title":"Int. J. Psychiatr. Med."},{"issue":"2","key":"10.1016\/j.bbih.2025.101015_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.bbih.2025.101015_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3390\/nu10111707","article-title":"Latent iron deficiency as a marker of negative symptoms in patients with first-episode schizophrenia spectrum disorder","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bbih.2025.101015_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.966439","article-title":"Peripheral inflammation levels associated with degree of advanced brain aging in schizophrenia","volume":"13","author":"Klaus","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101015_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.612471","article-title":"The role of peripheral inflammation in clinical outcome and brain imaging abnormalities in psychosis: a systematic review","volume":"12","author":"Kose","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101015_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113431","article-title":"Physical and mental health burden of caregivers of patients with psychiatric disorders","volume":"293","author":"Koutentaki","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbih.2025.101015_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpsychires.2017.06.003","article-title":"Resting-state functional connectivity of anterior and posterior hippocampus in posttraumatic stress disorder","volume":"94","author":"Lazarov","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbih.2025.101015_bib31","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.bbih.2025.101015_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0033291710001042","article-title":"Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder","volume":"41","author":"Lewandowski","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbih.2025.101015_bib33","article-title":"New insight in the cross-talk between microglia and schizophrenia: from the perspective of neurodevelopment","volume":"14","author":"Li","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101015_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.schres.2018.03.003","article-title":"Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia","volume":"199","author":"Liu","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101015_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.comppsych.2019.01.003","article-title":"Changes in serum TNF-\u03b1, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge","volume":"90","author":"Luo","year":"2019","journal-title":"Compr. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbih.2025.101015_bib36","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12640-018-9987-y","article-title":"In schizophrenia, increased plasma IgM\/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype","volume":"35","author":"Maes","year":"2019","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.bbih.2025.101015_bib37","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1007\/s12035-018-1437-6","article-title":"In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome","volume":"56","author":"Maes","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbih.2025.101015_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/15622975.2019.1701203","article-title":"In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde","volume":"21","author":"Maes","year":"2020","journal-title":"World J. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.bbih.2025.101015_bib39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101015_bib40","article-title":"Exploring the relationship of cognitive function with and without COVID-19 recovered schizophrenic patients","volume":"11","author":"Mehmood","year":"2023","journal-title":"Front. Public Health"},{"issue":"7","key":"10.1016\/j.bbih.2025.101015_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13195-020-00744-w","article-title":"Cognitive impact of COVID-19: looking beyond the short term","volume":"12","author":"Miners","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbih.2025.101015_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","article-title":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review","volume":"192","author":"Misiak","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101015_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114807","article-title":"Relationship between blood-based inflammatory indices and clinical score of schizophrenia patients: a cross-sectional study","volume":"460","author":"Mojadadi","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbih.2025.101015_bib45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/ijms23031217","article-title":"Neurobiological highlights of cognitive impairment in psychiatric disorders","volume":"23","author":"Morozova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbih.2025.101015_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105310","article-title":"Modeling psychotic disorders: environment x environment interaction","volume":"152","author":"Murlanova","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbih.2025.101015_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","article-title":"The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia","volume":"48","author":"Na","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbih.2025.101015_bib48","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1111\/ene.16027","article-title":"What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection","volume":"30","author":"Nicotra","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbih.2025.101015_bib49","doi-asserted-by":"crossref","unstructured":"Organization WH. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Clinical Descriptions & Diagnostic Guidelines Geneva. Published online 1993. doi:10.1002\/j.2051-5545.2011.tb00022.x.","DOI":"10.1002\/j.2051-5545.2011.tb00022.x"},{"issue":"10039","key":"10.1016\/j.bbih.2025.101015_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-022-02541-8","article-title":"Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia","volume":"19","author":"Petty","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/wps.20837","article-title":"The emergence of cognitive COVID","volume":"20","author":"Ritchie","year":"2021","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.bbih.2025.101015_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/neu.2022.11","article-title":"First-episode psychotic disorders in the wake of the COVID-19 pandemic: a descriptive review of casereports","volume":"34","author":"Rittmannsberger","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbih.2025.101015_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-030-41769-7_17","article-title":"Serum amyloid A (SAA) proteins","volume":"94","author":"Sack","year":"2020","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbih.2025.101015_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2024.03.014","article-title":"Cognitive and inflammatory heterogeneity in severe mental illness: translating findings from blood to brain","volume":"118","author":"S\u00e6ther","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2012.02.025","article-title":"Gastrointestinal inflammation and associated immune activation in schizophrenia","volume":"138","author":"Severance","year":"2012","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.bbih.2025.101015_bib57","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/ijerph18041434","article-title":"Assessment of the impact of a daily rehabilitation Program on anxiety and depression symptoms and the quality of life of people with mental disorders during the COVID-19 pandemic","volume":"18","author":"Smolarczyk-Kosowska","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"6","key":"10.1016\/j.bbih.2025.101015_bib58","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00406-023-01677-9","article-title":"The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-na\u00efve patients with schizophrenia","volume":"274","author":"Sun","year":"2024","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbih.2025.101015_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/7854_2018_88","article-title":"Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia","volume":"44","author":"Upthegrove","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.bbih.2025.101015_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.schres.2024.07.050","article-title":"Longitudinal relationships between BMI and hs-CRP among people with schizophrenia","volume":"271","author":"Van Dyne","year":"2024","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.bbih.2025.101015_bib61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbih.2025.101015_bib62","article-title":"Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbih.2025.101015_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"10.1016\/j.bbih.2025.101015_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbi.2023.10.012","article-title":"Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: a randomized control trial","volume":"115","author":"Weickert","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2025.101015_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.933642","article-title":"The Chinese brief cognitive test: normative data stratified by gender, age and education","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Psychiatr."},{"issue":"11","key":"10.1016\/j.bbih.2025.101015_bib66","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tics.2023.08.008","article-title":"Effects of COVID-19 on cognition and brain health","volume":"27","author":"Zhao","year":"2023","journal-title":"Trends Cognit. Sci."},{"issue":"1","key":"10.1016\/j.bbih.2025.101015_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12888-024-06163-7","article-title":"Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-\u03b1 levels in drug-naive individuals with first-episode schizophrenia","volume":"24","author":"Zhao","year":"2024","journal-title":"BMC Psychiatry"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:38:56Z","timestamp":1762637936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354625000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":67,"alternative-id":["S2666354625000730"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101015","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of dual inflammation on the acute phase clinical outcomes of schizophrenia patients with comorbid COVID-19","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101015"}}